Showing results (1821-1830 of 1,996) with videos related to

Sort By:
Pageof 200
The Lancet. Neurology|December 21, 2007
Strategies to advance translational research into brain barriersEdward Neuwelt, N Joan Abbott, Lauren Abrey, et al.
The Lancet. Neurology|April 15, 2014
Efficacy of occupational therapy for patients with Parkinson's disease: a randomised controlled trialIngrid H W M Sturkenboom, Maud J L Graff, Jan C M Hendriks, et al.
The Lancet. Neurology|April 2, 2014
Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trialPeter A Calabresi, Ernst-Wilhelm Radue, Douglas Goodin, et al.
The Lancet. Neurology|April 2, 2014
Neuropsychiatric outcomes of strokeMaree L Hackett, Sebastian Köhler, John T O'Brien, et al.
The Lancet. Neurology|April 8, 2014
Safety and efficacy of uric acid in patients with acute stroke (URICO-ICTUS): a randomised, double-blind phase 2b/3 trialAngel Chamorro, Sergio Amaro, Mar Castellanos, et al.
The Lancet. Neurology|April 8, 2014
A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem studyLidia Sabater, Carles Gaig, Ellen Gelpi, et al.
The Lancet. Neurology|March 29, 2014
End-of-life decisions in patients with severe acute brain injuryMarjolein Geurts, Malcolm R Macleod, Ghislaine J M W van Thiel, et al.
The Lancet. Neurology|May 3, 2014
Time to angiographic reperfusion and clinical outcome after acute ischaemic stroke: an analysis of data from the Interventional Management of Stroke (IMS III) phase 3 trialPooja Khatri, Sharon D Yeatts, Mikael Mazighi, et al.
The Lancet. Neurology|October 4, 2016
DNM3 and genetic modifiers of age of onset in LRRK2 Gly2019Ser parkinsonism: a genome-wide linkage and association studyJoanne Trinh, Emil K Gustavsson, Carles Vilariño-Güell, et al.
The Lancet. Neurology|March 25, 2017
Serotonin and dopamine transporter PET changes in the premotor phase of LRRK2 parkinsonism: cross-sectional studiesDaryl J Wile, Pankaj A Agarwal, Michael Schulzer, et al.
Pageof 200